연구물
33건 검색
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1N-Succinylaspart-1-yl Celecoxib is a Potential Colon-Specific Prodrug of Celecoxib with Improved Therapeutic Properties
- 연구출판물 · 학술지 논문JCR Q1N,N '-Bis(5-aminosalicyl)-L-Cystine Is a Potential Colon-Specific 5-Aminosalicylic Acid Prodrug with Dual Therapeutic Effects in Experimental Colitis
- 연구출판물 · 리뷰논문JCR Q2What should be considered on design of a colon-specific prodrug?
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole
- 연구출판물 · 학술지 논문Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone
- 연구출판물 · 학술지 논문Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Photo- and pH-Responsive Polycarbonate Block Copolymer Prodrug Nanomicelles for Controlled Release of Doxorubicin
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
- 연구출판물 · 학술지 논문JCR Q2Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-kappa B, an anti-inflammatory target
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes
- 연구출판물 · 학술지 논문JCR Q1Synthesis and Evaluation of N-Nicotinoyl-2-{2-(2-Methyl-5-Nitroimidazol-1-yl)Ethyloxy}-D,L-Glycine as a Colon-Specific Prodrug of Metronidazole
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Carbutamide, an Obsolete Anti-Diabetic Drug, Has Potential as a Potent Anticolitic Agent via Azo-Conjugation with Mesalazine
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis
- 연구출판물 · 학술지 논문JCR Q2An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: Taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1 beta-mediated NF kappa B activation
- 연구출판물 · 학술지 논문A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: A potential pharmacologic mechanism and therapeutic advantages
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis
- 연구출판물 · 학술지 논문JCR Q2Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent



로그인
홈
Researcher Page
ISNI
ORCID